doi:10.1007/s12035-022-02811-9
2 There is insufficient data to recommend other formulations of vitamin B 12 replacement (e.g., nasal, sublingual, subcutaneous)
This injectable fits the bill The company said it had received approval from the Central Drugs Standard Control Organisation (CDSCO) in February 2026 to manufacture and market the drug, following a clinical comparison study
Reported back discomfort is usually related to weight loss adaptation, muscle fatigue, posture changes, or hydration shifts during treatment
Larger, earlystage clinical trials are now needed to determine whether these promising signs actually translate into tangible benefits for patients. Key Questions Answered: Q: If Ozempic or Wegovy reduces amyloid, why didnt human trials show cognitive improvement yet